Optimising recruitment and informed consent in randomised controlled trials: the development and implementation of the Quintet Recruitment Intervention (QRI).
Pragmatic randomised controlled trials (RCTs) are considered essential to determine effective interventions for routine clinical practice, but many fail to recruit participants efficiently, and some really important RCTs are not undertaken because recruitment is thought to be too difficult. The 'QuinteT Recruitment Intervention' (QRI) aims to facilitate informed decision making by patients about RCT participation and to increase recruitment. This paper presents the development and implementation of the QRI.



The QRI developed iteratively as a complex intervention. It emerged from the National Institute for Health Research (NIHR) ProtecT trial and has been developed further in 13 RCTs. The final version of the QRI uses a combination of standard and innovative qualitative research methods with some simple quantification to understand recruitment and identify sources of difficulties.



The QRI has two major phases: understanding recruitment as it happens and then developing a plan of action to address identified difficulties and optimise informed consent in collaboration with the RCT chief investigator (CI) and the Clinical Trials Unit (CTU). The plan of action usually includes RCT-specific, as well as generic, aspects. The QRI can be used in two ways: it can be integrated into the feasibility/pilot or main phase of an RCT to prevent difficulties developing and optimise recruitment from the start, or it can be applied to an ongoing RCT experiencing recruitment shortfalls, with a view to rapidly improving recruitment and informed consent or gathering evidence to justify RCT closure.



The QRI provides a flexible way of understanding recruitment difficulties and producing a plan to address them while ensuring engaged and well-informed decision making by patients. It can facilitate recruitment to the most controversial and important RCTs. QRIs are likely to be of interest to the CIs and CTUs developing proposals for 'difficult' RCTs or for RCTs with lower than expected recruitment and to the funding bodies wishing to promote efficient recruitment in pragmatic RCTs.
School of Social and Community Medicine, University of Bristol, Bristol, BS8 2PR, UK. Jenny.Donovan@bristol.ac.uk.|Collaboration for Leadership in Applied Health Research and Care West at University Hospitals Bristol, Bristol, BS1 2NT, UK. Jenny.Donovan@bristol.ac.uk.
Jenny L
JL
Donovan
School of Social and Community Medicine, University of Bristol, Bristol, BS8 2PR, UK.
Leila
L
Rooshenas
School of Social and Community Medicine, University of Bristol, Bristol, BS8 2PR, UK.
Marcus
M
Jepson
School of Social and Community Medicine, University of Bristol, Bristol, BS8 2PR, UK.
Daisy
D
Elliott
School of Social and Community Medicine, University of Bristol, Bristol, BS8 2PR, UK.
Julia
J
Wade
School of Social and Community Medicine, University of Bristol, Bristol, BS8 2PR, UK.
Kerry
K
Avery
School of Social and Community Medicine, University of Bristol, Bristol, BS8 2PR, UK.
Nicola
N
Mills
School of Social and Community Medicine, University of Bristol, Bristol, BS8 2PR, UK.
Caroline
C
Wilson
School of Social and Community Medicine, University of Bristol, Bristol, BS8 2PR, UK.
Sangeetha
S
Paramasivan
School of Social and Community Medicine, University of Bristol, Bristol, BS8 2PR, UK.
Jane M
JM
Blazeby
D006801:Humans; D007258:Informed Consent; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic